Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 13;27(6):1857.
doi: 10.3390/molecules27061857.

Limitations of Phage Therapy and Corresponding Optimization Strategies: A Review

Jiaxi Lin  1   2 , Fangyuan Du  1   2 , Miao Long  1   2 , Peng Li  1   2
Affiliations
Review

Limitations of Phage Therapy and Corresponding Optimization Strategies: A Review

Jiaxi Lin et al. Molecules. .

Abstract

Bacterial infectious diseases cause serious harm to human health. At present, antibiotics are the main drugs used in the treatment of bacterial infectious diseases, but the abuse of antibiotics has led to the rapid increase in drug-resistant bacteria and to the inability to effectively control infections. Bacteriophages are a kind of virus that infects bacteria and archaea, adopting bacteria as their hosts. The use of bacteriophages as antimicrobial agents in the treatment of bacterial diseases is an alternative to antibiotics. At present, phage therapy (PT) has been used in various fields and has provided a new technology for addressing diseases caused by bacterial infections in humans, animals, and plants. PT uses bacteriophages to infect pathogenic bacteria so to stop bacterial infections and treat and prevent related diseases. However, PT has several limitations, due to a narrow host range, the lysogenic phenomenon, the lack of relevant policies, and the lack of pharmacokinetic data. The development of reasonable strategies to overcome these limitations is essential for the further development of this technology. This review article described the current applications and limitations of PT and summarizes the existing solutions for these limitations. This information will be useful for clinicians, people working in agriculture and industry, and basic researchers.

Keywords: applications; bacteriophage; existing solutions; limitations; phage therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Phage lysis cycle and lysogenic cycle.
See this image and copyright information in PMC

References

    1. Morens D.M., Folkers G.K., Fauci A.S. The challenge of emerging and re-emerging infectious diseases. Nature. 2004;430:242–249. doi: 10.1038/nature02759. - DOI - PMC - PubMed
    1. Lindahl J.F., Grace D. The consequences of human actions on risks for infectious diseases: A review. Infect. Ecol. Epidemiol. 2015;5:30048. doi: 10.3402/iee.v5.30048. - DOI - PMC - PubMed
    1. Wyatt C. Resistant Organisms and Their Approach to Management in Clinical and Emergency Care. Curr. Emerg. Hosp. Med. Rep. 2019;7:59–65. doi: 10.1007/s40138-019-00184-3. - DOI
    1. Lewis D.A. New treatment options for Neisseria gonorrhoeae in the era of emerging antimicrobial resistance. Sex Health. 2019;16:449–456. doi: 10.1071/SH19034. - DOI - PubMed
    1. Sarda C., Fazal F., Rello J. Management of ventilator-associated pneumonia (VAP) caused by resistant gram-negative bacteria: Which is the best strategy to treat? Expert Rev. Respir. Med. 2019;13:787–798. doi: 10.1080/17476348.2019.1632195. - DOI - PubMed

Substances